Search
Close this search box.
Contact Us

Way Towards New Life

Hepatitis C Medications

Alleviare promptly facilitates Indian patients and physicians under Named Patient Programs (NPP) to access imported authorized medicines that are not locally available to them.
Facebook Twitter Youtube

Get access to an unapproved drug for personal use.

Here is a list of some of the  Hepatitis C Medications for which we currently have a NPP in place. If you are a patient or  healthcare professional, please click below on each to access details and information.

OLYSIO (simeprevir) capsules

Olysio is an antiviral medicine that contains the active substance simeprevir. It is used to treat adults with chronic (long-term) hepatitis C, an infectious disease that affects the liver caused by the hepatitis C virus.
Click here

VIEKIRA PAK (ombitasvir, paritaprevir, and ritonavir tablets)

VIEKIRA PAK is a brand-name prescription drug that’s FDA-approved to treat genotype 1 chronic hepatitis C virus (HCV) infection including those with compensated cirrhosis.
Click here

VOSEVI (sofosbuvir, velpatasvir, and voxilaprevir) tablets

VOSEVI is a brand-name prescription drug that’s FDA-approved to treat hepatitis C virus (HCV) infection without cirrhosis.
Click here

ZEPATIER (elbasvir and grazoprevir) tablets

ZYDELIG is a brand-name prescription drug that’s FDA-approved to treat hepatitis C virus (HCV).
Click here

For Indian Patient Enquiry under NPP.

Email At
kamal.kaushal@alleviareindia.com
laxmi.singh@alleviareindia.com
Call At
+91 98182 74099 ( Kamal Kaushal)
+91 9289711088 (Ms. Laxmi Singh)
WhatsApp At
+91 98182 74099 ( Kamal Kaushal)
+91 9289711088 (Ms. Laxmi Singh)

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

Query Form

We would love to speak with you.
Feel free to reach out using the below details.

Get Access to an Unapproved Drug

Get access to an unapproved drug for personal use to following cities in India – Ahmedabad, Aizawal, Aurangabad, Barshi, Bengaluru, Bhopal, Cachar, Chennai, Dibrugarh, Hyderabad, Karungapally, Kohima, Kollam, Kolkata, Mumbai, Meghalaya, Mizoram, Sikkim, Nagpur, New Delhi, Pondichery, Pune, Punjab, Thirunananthapuram, Tripura, Wardha

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners. Alleviare provides only information & in any way, does not lay any claim on these brand names &/or trademarks.

Opening Hours:
Monday – Saturday 10am – 6pm
Email – contact@alleviareindia.com

Contact Address:
P: 011: 35017784 / 35017785
M/W: +91 9289711087 / 9289711088

Address:
Mezzanine Floor, S-9, Green Park Extension, South Delhi, Delhi, 110016

Instagram Facebook-f Linkedin

DISCLAIMER: The services of Alleviare Life Sciences do not replace a physician-patient relationship and are not intended as medical advice. Alleviare Life Sciences provides patients and physicians with new medicine options by providing safe and secure access to approved medicines from other countries. We only provide this service after the patient and physician have made a professional decision on the treatment.

© 2023 Alleviare Life Sciences Pvt. Ltd.

Terms and Conditions | Privacy Policy | Legal Disclaimer